We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+4.95%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$141M
AUM Growth
-$13.1M
Cap. Flow
+$7.45M
Cap. Flow %
5.29%
Top 10 Hldgs %
66.07%
Holding
39
New
3
Increased
3
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
CGAU
Centerra Gold
CGAU
+$8.4M
2
OBIO icon
Orchestra BioMed
OBIO
+$1.33M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$909K
4
ABEO icon
Abeona Therapeutics
ABEO
+$357K
5
RGLD icon
Royal Gold
RGLD
+$257K

Top Sells

Rank Stock Value
1
EQX icon
Equinox Gold
EQX
+$3.79M
2
SKE
Skeena Resources
SKE
+$252K

Sector Composition

Rank Sector Weight
1 Healthcare 54.97%
2 Materials 30.41%
3 Consumer Staples 1.78%
4 Industrials 1.73%
5 Financials 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WPM icon
26
Wheaton Precious Metals
WPM
$60.9B
$1.12M 0.8%
12,500
– –
NOC icon
27
Northrop Grumman
NOC
$81.2B
$1.08M 0.77%
2,165
– –
CDE icon
28
Coeur Mining
CDE
$17.9B
$852K 0.61%
96,132
– –
MREO
29
Mereo BioPharma
MREO
$47.3M
$706K 0.5%
260,470
– –
DEO icon
30
Diageo
DEO
$53.6B
$681K 0.48%
6,750
– –
VRNA
31
DELISTED
Verona Pharma
VRNA
$667K 0.47%
7,049
– –
NEWP
32
New Pacific Metals
NEWP
$1.17B
$650K 0.46%
485,000
– –
HOOK
33
DELISTED
HOOKIPA Pharma
HOOK
$626K 0.44%
498,625
– –
ABEO icon
34
Abeona Therapeutics
ABEO
$413M
$356K 0.25%
+62,689
New +$357K
CGAU
35
Centerra Gold
CGAU
$4.15B
$170K 0.12%
+1,227,863
New +$8.4M
OBIO icon
36
Orchestra BioMed
OBIO
$254M
$170K 0.12%
+455,128
New +$1.33M
CRDL
37
Cardiol Therapeutics
CRDL
$164M
$136K 0.1%
100,000
– –
EQX icon
38
Equinox Gold
EQX
$13.5B
– –
-550,811
Closed -$3.79M
1
2

Similar funds

FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return
V
ViaWealth Leawood, Kansas $180M AUM 20.16% 1-Year Est. Return
RVM
Robinson Value Management San Antonio, Texas $180M AUM 24.17% 1-Year Est. Return

Knoll Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Knoll Capital Management held 39 positions worth $141M, down 8.5% from $154M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Knoll Capital Management deployed $7.45M of net new capital in Q2 2025, opening 3 new positions and adding to 3 existing holdings. Its largest new stake was Centerra Gold: 1,227,863 shares worth $170K.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 62% a quarter earlier, followed by Materials and Consumer Staples.

On the sell side, the largest reduction was Skeena Resources, an estimated $252K trimmed.

  • Knoll Capital Management's largest Q2 2025 buy was Centerra Gold: 1,227,863 shares worth $170K.
  • Knoll Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2025, an estimated $909K increase.
  • Knoll Capital Management's biggest Q2 2025 reduction was Skeena Resources, cutting an estimated $252K.
  • Knoll Capital Management fully exited Equinox Gold in Q2 2025, selling an estimated $3.79M.
  • Knoll Capital Management's ten largest holdings make up 66% of its $141M portfolio in Q2 2025.
  • Knoll Capital Management opened 3 new positions and closed 1 in Q2 2025.
  • Knoll Capital Management's portfolio value fell 8.5% quarter-over-quarter to $141M.

Based on Knoll Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.